86193 - Clinical Audit: Treating Concomitant Asthma and Allergic Rhinitis

Welcome to this clinical audit, aimed at improving the diagnosis and management of concomitant asthma and allergic rhinitis (AR). The audit focuses on more accurate diagnosis of AR, which will facilitate individualised treatment plans and improved symptom control. Key focus areas: Astham, Allergic Rhinitis, Hayfever, Respiratory

Allergic rhinitis (hay fever) is one of the most common chronic respiratory conditions in Australia, with an estimated 3.2 million sufferers (AIHW 2010). It can cause significant irritation and discomfort, interfering with daily activities. 

In addition to reducing quality of life, AR is linked with the development of asthma. Approximately 2 million Australians suffer from asthma, and an estimated 700,000 patients have both asthma and AR (AIHW 2010). There is evidence that in patients who have concomitant AR and asthma, the asthma symptoms are more difficult to control, compared to patients with asthma alone (Van den Berge et al. 2002). 

Although there is no cure for AR, effective treatment is available. Evidence shows that treating AR, particularly with intranasal corticosteroids, can reduce asthma related hospital visits (Fuhlbrigge & Adams, 2003). Poorly controlled AR may be associated with asthma complications (Walls R et al).